PCSK9si: Interim Ph II data

Interim data from the double-blind, placebo-controlled, international Phase II ORION-1 trial in 501 patients with atherosclerotic cardiovascular

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE